ATE200289T1 - Derivate des carbapenem-3-carbonsäureesters - Google Patents

Derivate des carbapenem-3-carbonsäureesters

Info

Publication number
ATE200289T1
ATE200289T1 AT96941156T AT96941156T ATE200289T1 AT E200289 T1 ATE200289 T1 AT E200289T1 AT 96941156 T AT96941156 T AT 96941156T AT 96941156 T AT96941156 T AT 96941156T AT E200289 T1 ATE200289 T1 AT E200289T1
Authority
AT
Austria
Prior art keywords
pct
alkyl group
substituted
carbapenem
acid ester
Prior art date
Application number
AT96941156T
Other languages
English (en)
Inventor
Takao Abe
Toshio Kumagai
Original Assignee
Wyeth Lederle Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Lederle Japan Ltd filed Critical Wyeth Lederle Japan Ltd
Application granted granted Critical
Publication of ATE200289T1 publication Critical patent/ATE200289T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96941156T 1995-12-08 1996-12-04 Derivate des carbapenem-3-carbonsäureesters ATE200289T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34507695 1995-12-08
PCT/JP1996/003540 WO1997021712A1 (en) 1995-12-08 1996-12-04 Carbapenem-3-carboxylic acid ester derivatives

Publications (1)

Publication Number Publication Date
ATE200289T1 true ATE200289T1 (de) 2001-04-15

Family

ID=18374125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96941156T ATE200289T1 (de) 1995-12-08 1996-12-04 Derivate des carbapenem-3-carbonsäureesters

Country Status (14)

Country Link
US (1) US5886172A (de)
EP (1) EP0808315B1 (de)
JP (1) JP4667542B2 (de)
KR (1) KR19980702089A (de)
AT (1) ATE200289T1 (de)
AU (1) AU705408B2 (de)
CA (1) CA2211075A1 (de)
DE (1) DE69612374T2 (de)
ES (1) ES2156303T3 (de)
HU (1) HUP9801156A3 (de)
IL (1) IL121240A (de)
NO (1) NO973625D0 (de)
TW (1) TW420681B (de)
WO (1) WO1997021712A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100345468B1 (ko) * 2000-07-10 2002-07-26 한국과학기술연구원 신규 1-베타메틸카바페넴 유도체 및 그의 제조방법
KR100446432B1 (ko) * 2001-08-13 2004-08-30 한국화학연구원 2-벤조티아졸 카바페넴 유도체 및 그의 제조방법
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
JPWO2004035539A1 (ja) * 2002-10-18 2006-02-16 明治製菓株式会社 カルバペネム類の製造方法およびその製造に用いられる中間体
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
CN101868460A (zh) * 2007-11-23 2010-10-20 国际药品工业株式会社 2-芳基甲基吖丁啶-碳青霉烯-3-羧酸酯衍生物或其盐、其制备方法以及包含上述的药物组合物
US8394922B2 (en) 2009-08-03 2013-03-12 Medarex, Inc. Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
CN102532139A (zh) * 2010-12-07 2012-07-04 重庆医药工业研究院有限责任公司 一种替比培南的制备方法
CN102558181B (zh) * 2010-12-15 2015-04-22 石药集团中奇制药技术（石家庄）有限公司 一种碳青霉烯抗生素的制备方法
CN102731507B (zh) * 2011-04-13 2015-04-01 石药集团中奇制药技术（石家庄）有限公司 泰比培南晶型、其制备方法及其在制备药物中的应用
CN102757430B (zh) * 2011-04-29 2016-04-13 上海医药工业研究院 一种替比培南的制备方法
CN102775409B (zh) * 2011-05-10 2016-08-03 上海医药工业研究院 一种替比培南匹伏酯的中间体的制备方法
CN102584812B (zh) * 2011-11-18 2014-03-12 深圳万乐药业有限公司 一种泰比培南酯杂质的制备方法
CN102503940B (zh) * 2011-11-22 2013-12-25 深圳万乐药业有限公司 制备泰比培南酯开环杂质的方法
KR102215954B1 (ko) 2013-02-14 2021-02-15 브리스톨-마이어스 스큅 컴퍼니 튜부리신 화합물, 그의 제조 및 사용 방법
US10077287B2 (en) 2014-11-10 2018-09-18 Bristol-Myers Squibb Company Tubulysin analogs and methods of making and use
EA201991618A1 (ru) 2017-02-06 2020-01-30 Сперо Терапьютикс, Инк. Кристаллические формы тебипенема пивоксила, композиции, содержащие их, способы изготовления и способы применения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
IE66711B1 (en) * 1988-04-01 1996-01-24 Sankyo Co 2-(heterocyclylthio) carbapenem derivatives their preparation and their use as antibiotics
JPH06157532A (ja) * 1992-11-17 1994-06-03 Sankyo Co Ltd 結晶性カルバペネム化合物
AU682510B2 (en) * 1993-07-01 1997-10-09 Pfizer Japan Inc. 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives
JP3317604B2 (ja) * 1994-12-28 2002-08-26 日本ワイスレダリー株式会社 結晶形態のカルバペネム化合物

Also Published As

Publication number Publication date
KR19980702089A (ko) 1998-07-15
TW420681B (en) 2001-02-01
AU705408B2 (en) 1999-05-20
NO973625L (no) 1997-08-06
DE69612374T2 (de) 2001-07-12
CA2211075A1 (en) 1997-06-19
WO1997021712A1 (en) 1997-06-19
ES2156303T3 (es) 2001-06-16
NO973625D0 (no) 1997-08-06
US5886172A (en) 1999-03-23
AU1039997A (en) 1997-07-03
HUP9801156A3 (en) 1999-03-01
JP4667542B2 (ja) 2011-04-13
IL121240A0 (en) 1998-01-04
HUP9801156A2 (hu) 1998-09-28
IL121240A (en) 2001-08-08
EP0808315A1 (de) 1997-11-26
EP0808315B1 (de) 2001-04-04
DE69612374D1 (de) 2001-05-10
JPH11504039A (ja) 1999-04-06

Similar Documents

Publication Publication Date Title
ATE200289T1 (de) Derivate des carbapenem-3-carbonsäureesters
DE69529143T2 (de) Distamycin a analoga als antitumor- oder antivirale wirkstoffe
TW265337B (de)
IE861820L (en) 2-hydroxy-2-phenylethylaminotetralines
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
TW243449B (de)
TW263513B (de)
DK0601345T3 (da) Lægemiddel Indeholdende en imidazol-l-yl-forbindelse
DE69413831D1 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
GR3032022T3 (en) 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
ES2156212T3 (es) Derivados de azabicicloheptano n-substituidos como neurolepticos, etc.
IL105122A0 (en) Benzimidazole derivative for use as an anti-irritant
ATE110569T1 (de) Pharmazeutische zusammensetzung zur verbesserung von dysuria.
AU551901B2 (en) Substituted thienobenzodiazepinones
DK0707587T3 (da) Farmakologisk aktive enantiomerer
WO1999050252A3 (en) Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
ES2038389T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas.